Use of Statin Medications Following Diagnosis in Relation to Survival among Women with Ovarian Cancer.

Barbara N Harding Joseph A Chris DelaneyRenata R UrbanNoel S Weiss

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

Because, in most women, statin administration has limited side effects, a randomized trial of statins among patients with ovarian cancer may be warranted.

Keyphrases

cardiovascular disease
coronary artery disease
polycystic ovary syndrome
low density lipoprotein
pregnancy outcomes
type diabetes
free survival
metabolic syndrome
pregnant women
cervical cancer screening
adipose tissue
insulin resistance
skeletal muscle
breast cancer risk